Acute Porphyria Drug Database

Monograph

M09AX01 - Hyaluronic Acid
Not porphyrinogenic
NP

Rationale
Glycosaminoglycan. Non-CYP dependent metabolism.
Chemical description
Glycosaminoglycan used in intra- articular injection for treatment of kneejoint arthrosis. Eliminated from the joint fluid within 48 hours and broken down in the liver as well as in the lymphglands.

Similar drugs
Explore alternative drugs in similar therapeutic classes M09A / M09AX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Belgium
Hyalgan · Hyalgan 20 mg/2 ml sol. inj. i.artic. ser. préremplie
United Kingdom
Hyalgan · Hyalgan 20mg/2ml solution for injection pre-filled syringes
Denmark
Hyalgan
Poland
Hyalgan · Hyaluroprol · Natrii hyaluronas Medezin
Luxembourg
HYALGAN
Finland
Hyalgan
Latvia
Hyalgan
Serbia
Hyalgan · Hyalgan®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙